Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001104659-22-061591

10% owner sold 418,738 shares at an average $9.66 ($4,045,791)

From the SEC's structured data for this filing

Trades in this filing

F2 Vision SCS · 10% owner

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-12 Sale : show line 1 in the form −264,072 $9.25 $2,442,587 1,460,539 D
2022-05-13 Sale : show line 2 in the form −85,319 $9.96 $850,042 1,375,220 D
2022-05-13 Sale : show line 3 in the form −34,189 $10.48 $358,335 1,341,031 D
2022-05-16 Sale : show line 4 in the form −35,158 $11.23 $394,828 1,305,873 D
Open-market sales · 418,738 sh · avg $9.66 · $4,045,791
Loading xslF345X03/tm2215669-1_4seq1.xml…